22 Dec 2021
Mereo & UAB Announce Positive Top-line Results from the Phase 1b/2 COSTA study
VIEW PRESS RELEASE DOWNLOAD PDF (247KB)
13 Dec 2021
Biomarker Data from Phase 1b/2 Trial of Alvelestat in Bronchiolitis Obliterans Syndrome (BOS)
VIEW PRESS RELEASE DOWNLOAD PDF (156KB)
30 Nov 2021
Mereo Reports Interim Data from ACTIVATE Phase 1b/2 Study of Etigilimab
DOWNLOAD PDF (191KB) VIEW WEBCAST
09 Nov 2021
Mereo BioPharma to Present at Two Upcoming Investor Conferences
VIEW PRESS RELEASE DOWNLOAD PDF (139KB)
04 Nov 2021
Mereo Announces Data From Investigator-Sponsored Trial of Alvelestat In BOS
VIEW PRESS RELEASE DOWNLOAD PDF (142KB)

Corporate Presentation

View our latest Corporate Presentation

Corporate Presentation

Our Mission

Our mission is to provide new therapies to patients with life limiting oncology and rare diseases that have few, if any, other treatment options.

View more about us